nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—NGF—glaucoma	0.267	0.838	CbGaD
Clenbuterol—Bambuterol—Dipivefrin—glaucoma	0.174	0.533	CrCrCtD
Clenbuterol—TNF—glaucoma	0.0517	0.162	CbGaD
Clenbuterol—Bupranolol—Levobunolol—glaucoma	0.033	0.101	CrCrCtD
Clenbuterol—Bupranolol—Carteolol—glaucoma	0.033	0.101	CrCrCtD
Clenbuterol—ADRB2—Levobunolol—glaucoma	0.0317	0.105	CbGbCtD
Clenbuterol—ADRB2—Metipranolol—glaucoma	0.0317	0.105	CbGbCtD
Clenbuterol—ADRB1—Levobunolol—glaucoma	0.0312	0.103	CbGbCtD
Clenbuterol—ADRB1—Metipranolol—glaucoma	0.0312	0.103	CbGbCtD
Clenbuterol—Salbutamol—Carteolol—glaucoma	0.0292	0.0893	CrCrCtD
Clenbuterol—Salbutamol—Levobunolol—glaucoma	0.0292	0.0893	CrCrCtD
Clenbuterol—ADRB3—Timolol—glaucoma	0.0287	0.095	CbGbCtD
Clenbuterol—Bupranolol—Timolol—glaucoma	0.0281	0.0859	CrCrCtD
Clenbuterol—ADRB2—Carteolol—glaucoma	0.027	0.0892	CbGbCtD
Clenbuterol—ADRB1—Carteolol—glaucoma	0.0266	0.0879	CbGbCtD
Clenbuterol—ADRB2—Dipivefrin—glaucoma	0.0192	0.0636	CbGbCtD
Clenbuterol—ADRB2—Betaxolol—glaucoma	0.0182	0.0603	CbGbCtD
Clenbuterol—ADRB1—Betaxolol—glaucoma	0.0179	0.0594	CbGbCtD
Clenbuterol—ADRB2—Timolol—glaucoma	0.0117	0.0388	CbGbCtD
Clenbuterol—ADRB1—Timolol—glaucoma	0.0116	0.0383	CbGbCtD
Clenbuterol—CYP1A1—Clonidine—glaucoma	0.0068	0.0225	CbGbCtD
Clenbuterol—CYP1A2—Betaxolol—glaucoma	0.00554	0.0183	CbGbCtD
Clenbuterol—CYP1A2—Clonidine—glaucoma	0.00304	0.0101	CbGbCtD
Clenbuterol—ADRB2—Treprostinil—Latanoprost—glaucoma	0.000861	1	CbGdCrCtD
Clenbuterol—TNF—Adipogenesis—NR3C1—glaucoma	3.45e-05	0.000666	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—PTGFR—glaucoma	3.44e-05	0.000664	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—BDNF—glaucoma	3.38e-05	0.000652	CbGpPWpGaD
Clenbuterol—NGF—SIDS Susceptibility Pathways—TNF—glaucoma	3.37e-05	0.000651	CbGpPWpGaD
Clenbuterol—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—glaucoma	3.35e-05	0.000647	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—FAS—glaucoma	3.35e-05	0.000646	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—IL1A—glaucoma	3.24e-05	0.000626	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—CDKN2A—glaucoma	3.19e-05	0.000616	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—BDNF—glaucoma	3.18e-05	0.000615	CbGpPWpGaD
Clenbuterol—NGF—MAPK Signaling Pathway—TNF—glaucoma	3.18e-05	0.000613	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	3.14e-05	0.000606	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—PTGFR—glaucoma	3.12e-05	0.000603	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—SMO—glaucoma	3.07e-05	0.000592	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—IL1A—glaucoma	3.06e-05	0.00059	CbGpPWpGaD
Clenbuterol—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	3.03e-05	0.000585	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—NGF—glaucoma	3e-05	0.000579	CbGpPWpGaD
Clenbuterol—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	2.99e-05	0.000578	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—NR3C1—glaucoma	2.98e-05	0.000576	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—NCK2—glaucoma	2.96e-05	0.000571	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—LRP12—glaucoma	2.96e-05	0.00057	CbGpPWpGaD
Clenbuterol—CYP1A1—PPARA activates gene expression—ABCA1—glaucoma	2.93e-05	0.000565	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—CDKN1B—glaucoma	2.91e-05	0.000562	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—FAS—glaucoma	2.91e-05	0.000561	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	2.89e-05	0.000558	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—PTGS2—glaucoma	2.87e-05	0.000555	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	2.87e-05	0.000555	CbGpPWpGaD
Clenbuterol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCA1—glaucoma	2.87e-05	0.000553	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—NGF—glaucoma	2.83e-05	0.000545	CbGpPWpGaD
Clenbuterol—CYP1A2—Phase II conjugation—GSTT1—glaucoma	2.8e-05	0.000541	CbGpPWpGaD
Clenbuterol—NGF—MAPK Signaling Pathway—TP53—glaucoma	2.8e-05	0.000541	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—RPTOR—glaucoma	2.79e-05	0.000538	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—BCL2L1—glaucoma	2.74e-05	0.000529	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—FAS—glaucoma	2.72e-05	0.000526	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—NCK2—glaucoma	2.7e-05	0.000521	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.66e-05	0.000513	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	2.65e-05	0.000512	CbGpPWpGaD
Clenbuterol—CYP1A1—Biological oxidations—GSTT1—glaucoma	2.57e-05	0.000496	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	2.51e-05	0.000485	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	2.51e-05	0.000485	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—BAD—glaucoma	2.49e-05	0.00048	CbGpPWpGaD
Clenbuterol—CYP1A1—Arachidonic acid metabolism—PTGS2—glaucoma	2.48e-05	0.000479	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—VEGFA—glaucoma	2.47e-05	0.000476	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	2.46e-05	0.000475	CbGpPWpGaD
Clenbuterol—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	2.46e-05	0.000475	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.32e-05	0.000448	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—HDAC9—glaucoma	2.3e-05	0.000443	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—PTGS2—glaucoma	2.27e-05	0.000439	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—OPN4—glaucoma	2.27e-05	0.000437	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—OPN4—glaucoma	2.22e-05	0.000428	CbGpPWpGaD
Clenbuterol—TNF—Folate Metabolism—TP53—glaucoma	2.15e-05	0.000416	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—CDKN1B—glaucoma	2.15e-05	0.000416	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	2.1e-05	0.000406	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	2.09e-05	0.000403	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—OPN4—glaucoma	2.06e-05	0.000397	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—OPN4—glaucoma	2.05e-05	0.000395	CbGpPWpGaD
Clenbuterol—CYP1A1—Biological oxidations—CYP1B1—glaucoma	2.05e-05	0.000395	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—PTGFR—glaucoma	2.04e-05	0.000394	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—EDN1—glaucoma	2.02e-05	0.00039	CbGpPWpGaD
Clenbuterol—CYP1A1—Metapathway biotransformation—CYP1B1—glaucoma	2.02e-05	0.00039	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—OPN4—glaucoma	2.01e-05	0.000389	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—PTGFR—glaucoma	2e-05	0.000385	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—MMP9—glaucoma	1.99e-05	0.000385	CbGpPWpGaD
Clenbuterol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—glaucoma	1.97e-05	0.000381	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—PAX6—glaucoma	1.92e-05	0.00037	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	1.91e-05	0.000369	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—HEYL—glaucoma	1.9e-05	0.000368	CbGpPWpGaD
Clenbuterol—TNF—Alzheimers Disease—TP53—glaucoma	1.87e-05	0.00036	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PTGFR—glaucoma	1.85e-05	0.000358	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PTGFR—glaucoma	1.84e-05	0.000356	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—SMO—glaucoma	1.82e-05	0.000351	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PTGFR—glaucoma	1.81e-05	0.00035	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—NARFL—glaucoma	1.8e-05	0.000348	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CA5A—glaucoma	1.8e-05	0.000348	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—SMO—glaucoma	1.8e-05	0.000347	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—TNF—glaucoma	1.79e-05	0.000345	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	1.79e-05	0.000345	CbGpPWpGaD
Clenbuterol—CYP1A2—Phase II conjugation—GSTM1—glaucoma	1.78e-05	0.000344	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—SMO—glaucoma	1.78e-05	0.000344	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—TP53—glaucoma	1.78e-05	0.000343	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—C3—glaucoma	1.77e-05	0.000341	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—LRP12—glaucoma	1.75e-05	0.000339	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—LRP12—glaucoma	1.72e-05	0.000331	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	1.69e-05	0.000326	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—NTRK2—glaucoma	1.64e-05	0.000317	CbGpPWpGaD
Clenbuterol—CYP1A2—Biological oxidations—GSTT1—glaucoma	1.64e-05	0.000316	CbGpPWpGaD
Clenbuterol—CYP1A1—Biological oxidations—GSTM1—glaucoma	1.64e-05	0.000316	CbGpPWpGaD
Clenbuterol—CYP1A1—Metapathway biotransformation—GSTM1—glaucoma	1.61e-05	0.000312	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	1.6e-05	0.000309	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	1.6e-05	0.000309	CbGpPWpGaD
Clenbuterol—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	1.58e-05	0.000305	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	1.58e-05	0.000304	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—SMO—glaucoma	1.57e-05	0.000304	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	1.55e-05	0.000299	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	1.54e-05	0.000298	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	1.46e-05	0.000283	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—RPTOR—glaucoma	1.44e-05	0.000279	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—VEGFA—glaucoma	1.43e-05	0.000276	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—NGFR—glaucoma	1.41e-05	0.000272	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NCK2—glaucoma	1.4e-05	0.00027	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.38e-05	0.000266	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—TP53—glaucoma	1.35e-05	0.000261	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.35e-05	0.00026	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—NTRK1—glaucoma	1.34e-05	0.000259	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	1.33e-05	0.000257	CbGpPWpGaD
Clenbuterol—CYP1A2—Biological oxidations—CYP1B1—glaucoma	1.31e-05	0.000252	CbGpPWpGaD
Clenbuterol—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	1.29e-05	0.000249	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CDKN2B—glaucoma	1.24e-05	0.000238	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	1.22e-05	0.000235	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	1.22e-05	0.000235	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—OPN4—glaucoma	1.22e-05	0.000235	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—EDN1—glaucoma	1.2e-05	0.000232	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—OPN4—glaucoma	1.19e-05	0.00023	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—HDAC9—glaucoma	1.19e-05	0.000229	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—EDN1—glaucoma	1.19e-05	0.000229	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—EDN1—glaucoma	1.17e-05	0.000227	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CA5A—glaucoma	1.15e-05	0.000222	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—NARFL—glaucoma	1.15e-05	0.000222	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—EDN1—glaucoma	1.14e-05	0.000221	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	1.14e-05	0.00022	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	1.14e-05	0.00022	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HEYL—glaucoma	1.13e-05	0.000218	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HEYL—glaucoma	1.11e-05	0.000213	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PTGFR—glaucoma	1.09e-05	0.000211	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—TP53—glaucoma	1.09e-05	0.00021	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PTGFR—glaucoma	1.07e-05	0.000207	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—C3—glaucoma	1.05e-05	0.000202	CbGpPWpGaD
Clenbuterol—CYP1A2—Biological oxidations—GSTM1—glaucoma	1.04e-05	0.000202	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—EDN1—glaucoma	1.04e-05	0.0002	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—C3—glaucoma	1.04e-05	0.0002	CbGpPWpGaD
Clenbuterol—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	1.03e-05	0.000199	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—C3—glaucoma	1.03e-05	0.000198	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—TP53—glaucoma	1.02e-05	0.000197	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—C3—glaucoma	9.98e-06	0.000193	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—APOE—glaucoma	9.64e-06	0.000186	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CAV1—glaucoma	9.55e-06	0.000184	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—SMO—glaucoma	9.34e-06	0.00018	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—SMO—glaucoma	9.3e-06	0.00018	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	9.2e-06	0.000178	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—SMO—glaucoma	9.14e-06	0.000176	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—FN1—glaucoma	9.09e-06	0.000175	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—C3—glaucoma	9.07e-06	0.000175	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—BAD—glaucoma	8.98e-06	0.000173	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CA1—glaucoma	8.8e-06	0.00017	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RPTOR—glaucoma	8.57e-06	0.000165	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CTSA—glaucoma	8.52e-06	0.000164	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NTRK2—glaucoma	8.51e-06	0.000164	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—MMP2—glaucoma	8.44e-06	0.000163	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RPTOR—glaucoma	8.38e-06	0.000162	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NCK2—glaucoma	8.3e-06	0.00016	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NCK2—glaucoma	8.12e-06	0.000157	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CA2—glaucoma	8.05e-06	0.000155	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	7.86e-06	0.000152	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	7.86e-06	0.000152	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NGFR—glaucoma	7.3e-06	0.000141	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—NOS3—glaucoma	7.22e-06	0.000139	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HDAC9—glaucoma	7.05e-06	0.000136	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NTRK1—glaucoma	6.93e-06	0.000134	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HDAC9—glaucoma	6.9e-06	0.000133	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—EDN1—glaucoma	6.78e-06	0.000131	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—EDN1—glaucoma	6.64e-06	0.000128	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CDKN2B—glaucoma	6.39e-06	0.000123	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—MMP9—glaucoma	6.34e-06	0.000122	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CDKN1B—glaucoma	6.26e-06	0.000121	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—EDN1—glaucoma	6.16e-06	0.000119	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—EDN1—glaucoma	6.13e-06	0.000118	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—EDN1—glaucoma	6.03e-06	0.000116	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—C3—glaucoma	5.93e-06	0.000114	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—C3—glaucoma	5.8e-06	0.000112	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MMP9—glaucoma	5.79e-06	0.000112	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—VEGFA—glaucoma	5.7e-06	0.00011	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—TXN—glaucoma	5.67e-06	0.000109	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NGF—glaucoma	5.63e-06	0.000109	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CA1—glaucoma	5.61e-06	0.000108	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SMO—glaucoma	5.52e-06	0.000107	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CTSA—glaucoma	5.43e-06	0.000105	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SMO—glaucoma	5.4e-06	0.000104	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—C3—glaucoma	5.38e-06	0.000104	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—C3—glaucoma	5.36e-06	0.000103	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—C3—glaucoma	5.26e-06	0.000102	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—VEGFA—glaucoma	5.2e-06	0.0001	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—APOE—glaucoma	5.17e-06	9.99e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CA2—glaucoma	5.13e-06	9.9e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	5.13e-06	9.89e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NTRK2—glaucoma	5.05e-06	9.74e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	5.01e-06	9.68e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	5.01e-06	9.68e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—APOE—glaucoma	4.99e-06	9.63e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CAV1—glaucoma	4.94e-06	9.54e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NTRK2—glaucoma	4.94e-06	9.53e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—FN1—glaucoma	4.7e-06	9.08e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—BAD—glaucoma	4.65e-06	8.97e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GSTT1—glaucoma	4.4e-06	8.49e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NGFR—glaucoma	4.33e-06	8.36e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NGFR—glaucoma	4.24e-06	8.18e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NTRK1—glaucoma	4.12e-06	7.94e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NTRK1—glaucoma	4.03e-06	7.77e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TP53—glaucoma	3.93e-06	7.59e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CDKN2B—glaucoma	3.79e-06	7.32e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NOS3—glaucoma	3.74e-06	7.21e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CDKN2B—glaucoma	3.71e-06	7.16e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—EDN1—glaucoma	3.64e-06	7.02e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—TXN—glaucoma	3.61e-06	6.98e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—EDN1—glaucoma	3.56e-06	6.87e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.54e-06	6.84e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CYP1B1—glaucoma	3.5e-06	6.76e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ABCA1—glaucoma	3.5e-06	6.76e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NGF—glaucoma	3.34e-06	6.46e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.3e-06	6.37e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NGF—glaucoma	3.27e-06	6.31e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.27e-06	6.31e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CDKN1B—glaucoma	3.24e-06	6.25e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—C3—glaucoma	3.18e-06	6.14e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—C3—glaucoma	3.11e-06	6e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MMP9—glaucoma	3e-06	5.79e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—APOE—glaucoma	2.96e-06	5.71e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CAV1—glaucoma	2.93e-06	5.66e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—APOE—glaucoma	2.9e-06	5.59e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CAV1—glaucoma	2.87e-06	5.54e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTT1—glaucoma	2.8e-06	5.41e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GSTM1—glaucoma	2.8e-06	5.4e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—FN1—glaucoma	2.79e-06	5.39e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—BAD—glaucoma	2.76e-06	5.32e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—FN1—glaucoma	2.73e-06	5.27e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—BAD—glaucoma	2.7e-06	5.21e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—VEGFA—glaucoma	2.69e-06	5.2e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—MTHFR—glaucoma	2.47e-06	4.78e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—APOE—glaucoma	2.3e-06	4.45e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CAV1—glaucoma	2.28e-06	4.41e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.26e-06	4.36e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CYP1B1—glaucoma	2.23e-06	4.31e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ABCA1—glaucoma	2.23e-06	4.31e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NOS3—glaucoma	2.22e-06	4.28e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NOS3—glaucoma	2.17e-06	4.19e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TP53—glaucoma	2.03e-06	3.93e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CDKN1B—glaucoma	1.92e-06	3.71e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CDKN1B—glaucoma	1.88e-06	3.63e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTM1—glaucoma	1.79e-06	3.45e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MMP9—glaucoma	1.78e-06	3.43e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MMP9—glaucoma	1.74e-06	3.36e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—NOS3—glaucoma	1.73e-06	3.33e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—VEGFA—glaucoma	1.6e-06	3.08e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PTGS2—glaucoma	1.58e-06	3.05e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—MTHFR—glaucoma	1.58e-06	3.05e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—VEGFA—glaucoma	1.56e-06	3.02e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—APOE—glaucoma	1.47e-06	2.84e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CAV1—glaucoma	1.46e-06	2.81e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TP53—glaucoma	1.21e-06	2.33e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TP53—glaucoma	1.18e-06	2.28e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—NOS3—glaucoma	1.1e-06	2.12e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PTGS2—glaucoma	1.01e-06	1.94e-05	CbGpPWpGaD
